Logo

Medtronic’s Freezor and Freezor Xtra Cardiac Cryoablation Focal Catheters Receives the US FDA’s Expanded Approval for AVNRT

Share this
Medtronic’s Freezor and Freezor Xtra Cardiac Cryoablation Focal Catheters Receives the US FDA’s Expanded Approval for AVNRT

Medtronic’s Freezor and Freezor Xtra Cardiac Cryoablation Focal Catheters Receives the US FDA’s Expanded Approval for AVNRT

Shots:

  • The US FDA has approved the Freezor and Freezor Xtra cardiac cryoablation focal catheters for the treatment of pediatric atrioventricular nodal reentrant tachycardia (AVNRT)
  • The approval was based on the (ICY-AVNRT) and multiple pediatric studies that showed the safety and effectiveness of Freezor and Freezor Xtra cardiac cryoablation catheters & reported the acute procedural success of 95% with no permanent pacemaker due to complete AV block along with high efficacy rates and low AEs
  • The freezor cryoablation catheters also includes the freezor MAX cardiac cryoablation catheter which is approved for use in conjunction with the Arctic Front Advance cryoballoon for AF

 Ref: Medtronic | Image: Medtronic

Click here to­ read the full press release 

Tuba

Tuba was Senior Editor at PharmaShots. She was curious, creative, and passionate about recent updates and innovations in the life sciences industry. She covered Biopharma, MedTech, and Digital health segments. Tuba also had an experience in digital and social media marketing and ran the campaigns independently. She can be contacted at connect@pharmashots.com.

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions